Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:12:48.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A new Revision: v3.5.0 label appears, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:12:10.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3 in the footer. This is a metadata update and does not affect study details or user actions.
    Difference
    0.1%
    Check dated 2026-03-11T16:39:48.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, and the previous Notice about lapse in government funding and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:57:10.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A system notice about potential processing delays due to a lapse in government funding was added, the NIH Clinical Center is open, and the page revision was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:41:20.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Show glossary feature added; new labels include 'Last Update Submitted that Met QC Criteria' and the footer 'Revision: v3.4.0'. The previous QC label 'Last Update Submitted that met QC Criteria', 'No FEAR Act data' and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:27:56.000Z thumbnail image

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.